VCYT

Veracyte, Inc.

Healthcare›Biotechnology|NASDAQ Global Market|US

Price

$32.25

Market Cap

$2.56B

Beta

1.96

P/E

40.8

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+16.01%

EPS Growth (YoY)+171.83%

Revenue CAGR 3Y+20.37%

P/E Ratio40.8

PEG Ratio0.23

FCF Yield+4.92%

Debt / Equity0.03

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for VCYT.